The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Open accessAbstract
Background: Methylphenidate (MPH) is the classic treatment for Attention Deficit Hyperactivity Disorder (ADHD), yet the mechanisms underlying its therapeutic actions remain unclear. Recent studies have identified an oral, MPH dose regimen which when given to rats produces drug plasma levels similar to those measured in humans. The current study examined the effects of these low, orally-administered doses of MPH in rats performing a delayed alternation task dependent on prefrontal cortex (PFC), a brain region that is dysfunctional in ADHD, and is highly sensitive to levels of catecholamines. The receptor mechanisms underlying the enhancing effects of MPH were explored by challenging the MPH response with the noradrenergic α2 adrenoceptor antagonist, idazoxan, and the dopamine D1 antagonist, SCH23390. Results: MPH produced an inverted U dose response whereby moderate doses (1.0–2.0 mg/kg, p.o.) significantly improved delayed alternation performance, while higher doses (2.0–3.0 mg/kg, p.o.) produced perseverative errors in many animals. The enhancing effects of MPH were blocked by co-administration of either the α2 adrenoceptor antagonist, idazoxan, or the dopamine D1 antagonist, SCH23390, in doses that had no effect on their own. Conclusion: The administration of low, oral doses of MPH to rats has effects on PFC cognitive function similar to those seen in humans and patients with ADHD. The rat can thus be used as a model for examination of neural mechanisms underlying the therapeutic effects of MPH on executive functions in humans. The efficacy of idazoxan and SCH23390 in reversing the beneficial effects of MPH indicate that both noradrenergic α2 adrenoceptor and dopamine D1 receptor stimulation contribute to cognitive-enhancing effects of MPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lower doses in rats improve PFC attention and working memory function, enhance PFC neuronal response, and reduce locomotor hyperactivity in juveniles (Arnsten and Dudley, 2005; Berridge et al., 2006; Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that therapeutic doses of methylphenidate and atomoxetine improve PFC function by increasing endogenous NE stimulation of α2-receptors and DA stimulation of D1-receptors in rats (Arnsten and Dudley, 2005) and monkeys (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our study reveals that stimulants may upregulate neuroimaging activation patterns in the left cerebellum compared to controls given their indirect phosphorylation of the glutamate receptor through modulating the release of norepinephrine”
From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Arnsten & Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This observation is in line with previous research demonstrating that children with ADHD tend to show impaired planning abilities (e.g., Clarke, Prior, & Kinsella, 2000) that can be restored with MPH (e.g., Arnsten & Dudley, 2005).”
From Implementation Intentions Facilitate Response Inhibition in Children with ADHD (2008) · cites this paper as Arnsten & Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, recent physiological studies have shown that NE strengthens network connectivity of the PFC and maintains persistent firing of PFC neurons during working memory tasks through stimulation of postsynaptic α2-adrenoceptors (Arnsten and Dudley, 2005).”
From The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD (2015) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“When administered in appropriate doses, these medications improve PFC function both in healthy human subjects (Elliott et al., 1997) and in animals (Arnsten and Dudley, 2005), including the reduction of locomotor hyperactivity in juvenile rats (Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
The cited source says what the claim attributes to it.
In the citing paper
“This article reviews studies in animals showing that norepinephrine and dopamine enhance PFC function through actions at postsynaptic α2A-adrenoceptors and dopamine D1-receptors, respectively.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Goldman-Rakic, P. S. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0129 · Cited by 1,072
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Self-citationVaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
(1964) · McGraw-Hill eBooks · Cited by 838
Zahrt, J., Taylor, J. R., Mathew, R. G., & Arnsten, A. F. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08528.1997 · Cited by 796
Self-citationBarkley, R. A., Grodzinsky, G., & DuPaul, G. J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916547 · Cited by 724
Flagged first, then by citations
Research works printed but not linked: 1
- Arnsten AFT, Castellanos FX: Neurobiology of attention regulation and its disorders. Textbook of Child and Adolescent Psychopharmacology. Edited by: Martin A, Scahill L, Charney D and Leckman J. 2002, NY, Oxford Univ. Press, 99-109.
Cited by
Sorted by citations
Items 201–300 of 365
Stress Response, Brain Noradrenergic System and Cognition
Winklewski, P. J., Radkowski, M., Wszędybył-Winklewska, M., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_204 · Cited by 23
Behavioral response to methylphenidate challenge: Influence of early life parental care
Engert, V., Joober, R., Meaney, M. J., Hellhammer, D. H., & Pruessner, J. C. (2009) · Developmental Psychobiology · doi:10.1002/dev.20380 · Cited by 21
Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder
Hong, Q., Zhang, M., Xiao-qin, P., Guo, M., Li, F. Y., Tong, M., Chen, R.-H., Guo, X., & Chi, X. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.024 · Cited by 21
McNulty, C. J., Fallon, I. P., Amat, J., Sanchez, R. J., Leslie, N. R., Root, D. H., Maier, S. F., & Baratta, M. V. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01443-w · Cited by 22
Gene expression profiles in the prefrontal cortex of SHR rats by cDNA microarrays
Qiu, J., Hong, Q., Chen, R., Tong, M., Zhang, M., Fei, L., Xiao-qin, P., Guo, M., Guo, X., & Chi, X. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9596-1 · Cited by 20
Salman, T., Afroz, R., Nawaz, S., Mahmood, K., Haleem, D. J., & Zarina, S. (2021) · Biochimie · doi:10.1016/j.biochi.2021.08.009 · Cited by 18
Childress, A. C. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0020-1 · Cited by 19
Kotani, M., Kiyoshi, A., Murai, T., Nakako, T., Matsumoto, K., Matsumoto, A., Ikejiri, M., Ogi, Y., & Ikeda, K. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.028 · Cited by 22
Benn, A., & Robinson, E. S. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4458-8 · Cited by 19
The safety of extended-release drug formulations for the treatment of ADHD
Childress, A. C. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1317344 · Cited by 22
Dommett, E. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.001 · Cited by 21
Silveira, M. M., Murch, W. S., Clark, L., & Winstanley, C. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000203 · Cited by 22
Connor, D. F., Findling, R. L., Kollins, S. H., Sallee, F., López, F. A., Lyne, A., & Tremblay, G. (2010) · CNS Drugs · doi:10.2165/11537790-000000000-00000 · Cited by 101
Turner, K. M., Peak, J. N., & Burne, T. H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00437-9 · Cited by 18
Kharas, N., Whitt, H., Reyes-Vasquez, C., & Dafny, N. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.011 · Cited by 18
Diurnal differences in memory and learning in young and adult rats treated with methylphenidate
Gomes, K. M., Comim, C., Valvassori, S., Réus, G. Z., Inácio, C. G., Martins, M. R., Souza, R. P., & Quevedo, J. (2010) · Journal of neural transmission · doi:10.1007/s00702-010-0385-8 · Cited by 19
Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain
Urban, K. R., & Gao, W. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712455504 · Cited by 18
McLaurin, K. A., Li, H., Booze, R. M., Fairchild, A. J., & Mactutus, C. F. (2018) · Scientific Reports · doi:10.1038/s41598-017-18300-2 · Cited by 17
Rönnbäck, L., & Johansson, B. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.791984 · Cited by 17
Effects of DSP4 and methylphenidate on spatial memory performance in rats
Sontag, T. A., Hauser, J., Tucha, O. M., & Lange, K. W. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0067-x · Cited by 17
Peña, I. D., Lee, J. C., Lee, H. L., Woo, T. S., Lee, H. C., Sohn, A. R., & Cheong, J. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.090 · Cited by 17
Stimulants and growth in children with attention-deficit/hyperactivity disorder
Negrao, B. L., & Viljoen, M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.015 · Cited by 17
Methylphenidate alleviates manganese-induced impulsivity but not distractibility
Beaudin, S. A., Strupp, B. J., Uribe, W., Ysais, L., Strawderman, M. S., & Smith, D. R. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.03.005 · Cited by 17
Yang, L., Hong, Q., Zhang, M., Liu, X., Xiao-qin, P., Guo, M., Li, F., Guo, X., Tong, M., & Chi, X. (2013) · Brain Research · doi:10.1016/j.brainres.2013.03.030 · Cited by 16
Wheeler, T. L., Smith, L. N., Bachus, S. E., McDonald, C. G., Fryxell, K. J., & Smith, R. F. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.005 · Cited by 16
Pardey, M. C., Kumar, N. N., Goodchild, A. K., Clemens, K. J., Homewood, J., & Cornish, J. L. (2012) · Brain Sciences · doi:10.3390/brainsci2030375 · Cited by 17
Attention enhancing effects of methylphenidate are age-dependent
Bhattacharya, S. E., Shumsky, J. S., & Waterhouse, B. D. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.006 · Cited by 17
Britton, G. B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000472 · Cited by 18
Polli, F. S., & Kohlmeier, K. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107744 · Cited by 15
Umehara, M., Ago, Y., Kawanai, T., Fujita, K., Hiramatsu, N., Takuma, K., & Matsuda, T. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283633648 · Cited by 15
Aasen, I. E., Øgrim, G., Kropotov, J. D., & Brunner, J. F. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.02.011 · Cited by 15
Tremblay, S., Pieper, F., Sachs, A. J., Joober, R., & Martínez-Trujillo, J. (2019) · eNeuro · doi:10.1523/eneuro.0371-18.2018 · Cited by 15
Rowan, J. D., McCarty, M. K., Kundey, S. M. A., Osburn, C., Renaud, S. M., Kelley, B. M., Matoushek, A. W., & Fountain, S. B. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.07.007 · Cited by 15
Methylphenidate for α-interferon induced depression
Camacho, A., & Ng, B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063134 · Cited by 15
The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment
Sun, H., Wu, M., Wang, M., Zhang, X., & Zhu, J. Z. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1032607 · Cited by 14
The effects of the neurotoxin DSP4 on spatial learning and memory in Wistar rats
Hauser, J., Sontag, T. A., Tucha, O. M., & Lange, K. W. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0076-4 · Cited by 14
The Neurobiological Basis of Attention-Deficit/Hyperactivity Disorder
Arnsten, A. F. T., Berridge, C. W., & McCracken, J. T. (2009) · Primary psychiatry · Cited by 14
Self-citationDopamine and norepinephrine transporter inhibition for long-term fear memory enhancement
Pantoni, M. M., Carmack, S. A., Hammam, L., & Anagnostaras, S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112266 · Cited by 13
Dopamine and Glutamate Interactions in ADHD: Implications for the Future Neuropharmacology of ADHD
Erin, M., Theresa, C., Greg, A., & Paul, E. (2013) · InTech eBooks · doi:10.5772/54207 · Cited by 14
Park, S., Hong, S., Kim, J.-W., Yang, Y.-H., Park, M.-H., Kim, B., Shin, M., Yoo, H., & Cho, S.-C. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12050121 · Cited by 15
A REVIEW ON NATURAL MEMORY ENHANCERS (NOOTROPICS)
Joshi, P. (2013) · Cited by 14
Stimulant side effects and inverted-U: Implications for ADHD guidelines
Lévy, F. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412450754 · Cited by 14
Towers, A. E., Oelschlager, M. L., Lorenz, M. R., Gainey, S. J., McCusker, R. H., Krauklis, S. A., & Freund, G. G. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.025 · Cited by 14
Venkataraman, S. S., Claussen, C. M., & Dafny, N. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1647-x · Cited by 14
Venkataraman, S. S., Claussen, C. M., Joseph, M., & Dafny, N. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.008 · Cited by 13
Nakazawa, S., Murai, T., Miyauchi, M., Kotani, M., & Ikeda, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3978-y · Cited by 13
Current issues and trends in the diagnosis and treatment of adults with ADHD
Cumyn, L., Kolar, D., Keller, A., & Hechtman, L. T. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1375 · Cited by 13
Claussen, C. M., & Dafny, N. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.003 · Cited by 12
Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
da Silva, B. S., Leffa, D. T., Beys-da-Silva, W. O., Torres, I. L. S., Rovaris, D. L., Victor, M. M., Rohde, L. A., Mota, N. R., Oliveira, C. D., Berger, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0649-5 · Cited by 12
Effects of Methylphenidate on the Dopamine Transporter and Beyond
Zetterström, T., Quansah, E., & Grootveld, M. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_333 · Cited by 11
Pereira, M. D. S., Sathler, M. F., Valli, T. D. R., Marques, R. S., Ventura, A., Peccinalli, N. R., Fraga, M., Manhães, A. C., & Kubrusly, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141249 · Cited by 10
Poulton, A. S., & Nanan, R. K. H. (2014) · Australasian Psychiatry · doi:10.1177/1039856213517949 · Cited by 11
Huang, H.-C., Wu, L. S., Yu, S.-C., Wu, B., Lua, A. C., Lee, S.-M., & Liu, C. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.07.24 · Cited by 11
McBurney-Lin, J., Sun, Y., Tortorelli, L. S., Nguyen, Q. A. T., Haga‐Yamanaka, S., & Yang, H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108151 · Cited by 11
Klebe, S., Deuschl, G., & Stolze, H. (2006) · Movement Disorders · doi:10.1002/mds.20973 · Cited by 11
Gomes, K. M., de Souza, R. P., Valvassori, S. S., Réus, G. Z., Inácio, C. G., Martins, M. R., Comim, C. M., & Quevedo, J. (2009) · Current Neurovascular Research · doi:10.2174/156720209789630357 · Cited by 11
Espiritu, A. I., Hara, T., Tolledo, J. K., Blair, M., & Burhan, A. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1259481 · Cited by 10
Fresquet, N., Angst, M.-J., Schleef, C., Gobaille, S., & Sandner, G. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.047 · Cited by 10
Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder
Lévy, F. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s52844 · Cited by 10
Attenuation of maternal behavior in virgin CD-1 mice by methylphenidate hydrochloride
Leussis, M. P., Bond, T. L. Y., Hawken, C. M., & Brown, R. E. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.07.010 · Cited by 10
Eizaguirre, M. Á. V., & Aróstegui, J. A. I. (2014) · Revista de la Asociación Española de Neuropsiquiatría · doi:10.4321/s0211-57352014000100004 · Cited by 14
Delaney, J., Nathani, S., Tan, V., Chavez, C., Orr, A., Paek, J., Faraji, M., Setlow, B., & Urs, N. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01868-5 · Cited by 10
Morell, B. R., Rotenberg, A., Expósito, S. H., & Pascual‐Leone, Á. (2011) · Revista de Neurología · doi:10.33588/rn.5304.2011072 · Cited by 9
Rajkumar, R., Kumar, J. R., & Dawe, G. S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.07.003 · Cited by 9
Jones, Z., Vazquez, C. R., & Dafny, N. (2014) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2014.44020 · Cited by 9
Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys
Oemisch, M., Johnston, K., & Paré, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.019 · Cited by 10
The locus coeruleus noradrenergic system gates deficits in visual attention induced by chronic pain
Moazen, P., Torabi, M., Azizi, H., Fathollahi, Y., Mirnajafi‐Zadeh, J., & Semnanian, S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112600 · Cited by 9
Hieble, J. P. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00694-x · Cited by 9
Polyunsaturated fatty acids in the treatment of attention deficit hyperactivity disorder
Lange, K. W., Hauser, J., Kanaya, S., Kaunzinger, I., Lange, K. M., Makulska-Gertruda, E., Nakamura, Y., Sontag, T. A., & Tucha, L. (2014) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v4i6.8 · Cited by 8
Farias, T. L., Marinho, V., Carvalho, V., Rocha, K. D. M., da Silva, P. R. A., Silva, F. J. D. C., Teles, A. S., Gupta, D. S., Ribeiro, P. F. M., Velasques, B., et al. (2019) · Neurological Sciences · doi:10.1007/s10072-018-3699-1 · Cited by 10
Buchmann, J. A., Dück, A., Gierow, W., Zamorski, H., Heinicke, S., Heinrich, H., Hoeppner, J., Klauer, T., Reis, O., & Haessler, F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0349-z · Cited by 8
Carvallo, C., Contreras, D., Ugarte, G., Delgado, R., Pancetti, F. C., Rozas, C., Piña, R., Constandil, L., Zeise, M. L., & Morales, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01485 · Cited by 8
Pan, N., Ma, T., Liu, Y., Zhang, S., Hu, S., Shekara, A., Cao, H., Gong, Q., & Chen, Y. (2024) · Psychological Medicine · doi:10.1017/s003329172400285x · Cited by 7
Duval, F., Erb, A., Mokrani, M., Weiss, T., & Carcangiu, R. (2021) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20210010 · Cited by 7
A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory
Yang, Y., Lewis, M. M., Kong, L., & Mailman, R. B. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001215 · Cited by 7
Rieder, A. S., Júnior, O. V. R., Prauchner, G. R. K., & Wyse, Â. T. D. S. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111057 · Cited by 7
P300: avaliação do potencial evocado cognitivo em crianças com e sem TDAH
Borja, A., & Pondé, M. P. (2009) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v8i2.4071 · Cited by 7
Methylphenidate induces state-dependency of social recognition learning: Central components
Zinn, C. G., Bühler, L., Cavalcante, L. E. S., Schmidt, S. D., Ferreira, F. F., Zanini, M. L., Furini, C. R. G., Myskiw, J. D. C., & Izquierdo, I. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.002 · Cited by 7
Wonnenberg, P. M., & Zestos, A. G. (2020) · ECS Transactions · doi:10.1149/09707.0901ecst · Cited by 7
Montiel-Herrera, F., Batanero-Geraldo, A., López, J. C., Vargas, J. P., Quintero, E., & Díaz, E. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114526 · Cited by 5
Inagaki, R., Kita, S., Niwa, N., Fukunaga, K., Iwamoto, T., & Moriguchi, S. (2024) · FEBS Journal · doi:10.1111/febs.17339 · Cited by 6
Adam, L. C., Repantis, D., Konrad, B. N., Dresler, M., & Kühn, S. (2021) · Brain and Cognition · doi:10.1016/j.bandc.2021.105802 · Cited by 6
Hao, J., Beck, J., Zhou, X., Lackner, G. L., Johnston, R., Reinhard, M. R., Goldsmith, P., Hollinshead, S. P., Dehlinger, V., Filla, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01887 · Cited by 6
Evans, P., Golla, S., & Morris, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00018-8 · Cited by 7
Dafny, N., & Claussen, C. M. (2014) · Journal of Experimental Pharmacology · doi:10.2147/jep.s53497 · Cited by 6
To what extent do neurobiological sleep-waking processes support psychoanalysis?
Gottesmann, C. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)92012-6 · Cited by 5
Navarra, R. L., & Waterhouse, B. D. (2018) · Brain Research · doi:10.1016/j.brainres.2018.06.027 · Cited by 8
Mini-review: A possible role for galanin in post-traumatic stress disorder
Ullrich, D. C., & Gillavry, D. W. M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135980 · Cited by 5
Arnsten, A. F. T., & Vijayraghavan, S. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00373.2006 · Cited by 5
Self-citationFunctional diversity of dopamine axons in prefrontal cortex during classical conditioning
Abe, K., Kambe, Y., Majima, K., Hu, Z., Ohtake, M., Momennezhad, A., Izumi, H., Tanaka, T., Matunis, A., Stacy, E., et al. (2023) · eLife · doi:10.7554/elife.91136 · Cited by 21
Rubio, B. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-497-7.00012-7 · Cited by 4
Attention deficit hyperactivity disorder
Berridge, C. W., Devilbiss, D. M., Spencer, R. C., Schmeichel, B. E., & Arnsten, A. F. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.018 · Cited by 4
Self-citationThe catecholamine neuron: Historical and future perspectives
Bloom, F. E. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.014 · Cited by 6
Ritalin Dose Response Effect on Medial Prefrontal Cortex and on Animal Behavior
Reyes-Vasquez, C., Cannon, C. J., & Dafny, N. (2016) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2016.63015 · Cited by 4
Rehabilitación de las Funciones Ejecutivas en Caso de Patología Cerebral
Arango‐Lasprilla, J. C., & Parra, M. A. (2008) · Revista Neuropsicología, Neuropsiquiatría y Neurociencias · Cited by 4
Fuster, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407815-4.00003-9 · Cited by 4
Towards a Biological Understanding of ADHD and the Discovery of Novel Therapeutic Approaches
Tannock, R., Campbell, B., Seymour, P. A., Ouellet, D., Soares, H. D., Wang, P., & Chappell, P. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00010-2 · Cited by 4
The Brain Fatigue Syndrome—Symptoms, Probable Definition, and Pathophysiological Mechanisms
Johansson, B., & Rönnbäck, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103271 · Cited by 6
Berridge, C. W., & Devilbiss, D. M. (2012) · Psiquiatría Biológica · doi:10.1016/j.psiq.2012.07.001 · Cited by 3
Remaking Homo: ethical issues on future human enhancement
Saniotis, A. (2013) · Ethics in Science and Environmental Politics · doi:10.3354/esep00131 · Cited by 3
Metadata
- Authors
- Arnsten, A. F., & Dudley, A. G.
- Affiliations
- Yale University (US)
- Corresponding author
- Arnsten, Amy FT
- Venue
- Behavioral and Brain Functions
- Published
- 2005-04-22
- Volume
- 1
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1744-9081 (ISSN-L)
- PMC
- PMC1143775
- OpenAlex
- W2124264649
- Cited by
- 363
- References
- 70
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 17 · 2021: 7 · 2020: 8 · 2019: 14 · 2018: 13 · 2017: 19 · 2016: 18 · 2015: 16 · 2014: 27 · 2013: 28 · 2012: 27
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Behavioral and Brain Functions (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Shire
- National Institutes of Health (5r21mh066393-03)
- National Institute of Mental Health (R21-MH066393)
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, prefrontal cortex, delayed alternation, executive function, alpha2-adrenoceptors, dopamine D1 receptor, idazoxan, SCH 23390, noradrenergic signaling, dopamine signaling, perseverative errors, dose-response relationship, rat model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
